While the investigation found that sunitinib-treated tumors showed suppression of angiogenesis by analysis of several angiogenic markers, it also found an increased number of growing endothelial cells, suggesting that cessation of VEGF TKIs could cause quick revascularization of tumor after repression (92). This evidence concerns the gene VEGFA and neoplasm.